Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)

ASE:HPIC Revenue

Hayat Pharmaceutical Industries Co. had revenue of 4.45M JOD in the quarter ending June 30, 2026, with 32.04% growth. This brings the company's revenue in the last twelve months to 17.40M, up 7.35% year-over-year. In the year 2025, Hayat Pharmaceutical Industries Co. had annual revenue of 17.11M with 2.39% growth.

• Revenue (ttm): 17.40M
• Revenue Growth: +7.35%
• P/S Ratio: 1.75
• Revenue / Employee: 70.72K
• Employees: 246
• Market Cap: 30.40M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.11M	399.74K	2.39%
Dec 31, 2024	16.71M	903.56K	5.72%
Dec 31, 2023	15.81M	-1.30M	-7.61%
Dec 31, 2022	17.11M	522.31K	3.15%
Dec 31, 2021	16.58M	3.35K	0.02%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error